Pheromonicin Biotech Overview
- Year Founded
-
2008
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Pheromonicin Biotech General Information
Description
Operator of a research and development and preclinical-stage biopharmaceutical company in China. The company discovers and develops novel biological products for the treatment of various infectious diseases in a broad spectrum of species as well as for special applications in the non-infectious area, like killing the oncology cells in a mammal and inhibiting the water bloom issue caused by algae.
Contact Information
Website
www.china-pdl.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Primary Office
- 5# Kaituo Rd Biopharmaceutical Park
- Room B106
- Beijing, 100085
- China
Pheromonicin Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Apr-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 18-Dec-2010 | Completed | Generating Revenue |
Pheromonicin Biotech Patents
Pheromonicin Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20060264370-A1 | Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith | Active | 21-Jan-2005 | 000000000 | |
| US-7915382-B2 | Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith | Active | 21-Jan-2005 | 000000000 | |
| US-8652806-B2 | Nucleic acids encoding for antifungal bifunctional molecules for treating fungal infection | Active | 21-Jan-2005 | 000000000 | |
| US-8663916-B2 | Methods for producing antifungal bifunctional molecules for treating fungal infection | Active | 21-Jan-2005 | 000000000 | |
| US-8697640-B2 | Method for treating fungal infection with antifungal bifunctional molecules | Active | 21-Jan-2005 | C07K14/40 |
Pheromonicin Biotech Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Rongqi Li | Chief Executive Officer & Co-Founder | ||
| Jin Luo | Co-Founder, Chief Financial Officer & President | ||
| Xiaoqing Qiu | Co-Founder |